Kailyn Bell

Executive Director Business Development at Ergomed

Kailyn Bell has over 15 years of experience in the clinical research industry. Kailyn is currently working as the Sr. Director of Business Development at Ergomed, where they focus on global Phase I-IV clinical development and trial management. Prior to this, they served as the Senior Director of Business Development at Synteract, where they provided full-service, Phase I-IV services to biopharma companies. Kailyn also held roles at ERT, where they were the Senior Director of Strategic Accounts, Director of Strategic Partnerships, and Relationship Manager, and at ePharmaSolutions as an Associate Director of Clinical Solutions. Kailyn began their career as a Clinical Research Associate at Thomas Jefferson University. Throughout their career, Kailyn has demonstrated expertise in business development, strategic partnerships, project management, and clinical operations.

Kailyn Bell holds a Bachelor of Science (BS) degree in Comprehensive Science with a minor in Mathematics and Philosophy from Villanova University. Kailyn also has a Masters degree in Clinical Pharmacology from Thomas Jefferson University.

Location

Mullica Hill, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Ergomed

Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information.


Industries

Employees

1,001-5,000

Links